Literature DB >> 2486168

Dinitrochlorobenzene treatment of condylomata acuminata.

S Georgala1, I Danopoulou, A Katsarou.   

Abstract

Fifteen patients with treatment-resistant condylomata acuminata have been treated by application of Dinitrochlorobenzene (DNCB). The agent was applied weekly as a 0.5 or 1% solution in acetone for a period of 6 to 8 weeks. Patients were sensitised 15 days before the onset of treatment by applying a 2% DNCB solution on the right arm in a quantity of 0.15 ml. In one patient treatment had to be stopped because of local irritation and one discontinued treatment. In the other 13 patients all lesions cleared completely. Patients were followed up for a year and no recurrence has appeared as yet. DNCB seems to be useful agent for treatment-resistant condylomata acuminata and justifies further clinical trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2486168     DOI: 10.1111/j.1440-0960.1989.tb00430.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  Human papillomavirus, condylomata acuminata, and anal neoplasia.

Authors:  George J Chang; Mark L Welton
Journal:  Clin Colon Rectal Surg       Date:  2004-11

Review 2.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

3.  Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.

Authors:  D Mittal; I H Frazer; L S Tran; A-S Bergot; S R Mattarollo
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.